BRIEF-2Seventy Bio Enters Into Agreement To Be Acquired By Bristol Myers Squibb at $5.00 Per Share

Reuters
11 Mar
BRIEF-2Seventy Bio Enters Into Agreement To Be Acquired By Bristol Myers Squibb at $5.00 Per Share

March 10 (Reuters) - 2Seventy Bio Inc TSVT.O:

  • 2SEVENTY BIO ENTERS INTO DEFINITIVE AGREEMENT TO BE ACQUIRED BY BRISTOL MYERS SQUIBB

  • 2SEVENTY BIO INC - DEAL VALUED AT $5.00 PER SHARE, ALL-CASH TRANSACTION

  • 2SEVENTY BIO INC - TOTAL EQUITY VALUE OF APPROXIMATELY $286 MILLION

  • 2SEVENTY BIO INC - DEAL REPRESENTS 88% PREMIUM TO CLOSING PRICE

Source text: ID:nBw9fnF27a

Further company coverage: TSVT.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10